As a daughter of someone who had stage IV breast cancer, I like to consider myself fairly knowledgeable on the disease and some of the treatment options available (I’m no expert of course, but I experienced it first hand). However, about two weeks ago I got the chance to tour one of our research facilities and […]
Volleyball is Leading the Way Read More »
As a physician-scientist, I have been part of the Side-Out trial since 2009. The major goal of the trial is the improvement of survival rates of metastatic breast cancer patients through the delivery of what is known as “precision medicine.” But what does the term really mean? I have spent hundreds of hours at the
The Side-Out Protocol: A Scientist’s Perspective Read More »
GMU, With Ties to Italy, Aims to Be a Biotech Force By Michael Laris Wednesday, February 27, 2008; B01 The tiny pieces of tumor, cut from 51 Italian cancer patients, arrived at a suburban Washington laboratory in boxes packed with dry ice. Doctors at the University of Padua had frozen 51 nubs of tissue taken
In a Va. Lab, Forging Links to Speed Cancer Advances Read More »
Side-Out is a proud member of the
